Home » today » Health » Open latest COVID treatment guidelines for favipiravir, children under 18 – pregnant women can add LAAB as a drug – help people access

Open latest COVID treatment guidelines for favipiravir, children under 18 – pregnant women can add LAAB as a drug – help people access

The Department of Medical Services, Ministry of Public Health (MoPH) disseminates guidelines for the medical practice, diagnosis, treatment and prevention of nosocomial infections. Coronavirus disease 2019 (COVID-19) case for doctors and public health personnel The revised version dated November 30, 2022, with two main points: 1. Adjustment of antiretroviral drugs in adults and children according to various groups of symptoms 2. Adjustment of long-acting antibody (LABB) administration

to adjust the antiviral drug In the case of children under 18 with mild symptoms no pneumonia no risk factors Take care of the symptoms. Favipiravir can be given for 5 days. In pregnant women, favipiravir can be used in the second and third trimesters when indicated and the benefit outweighs the risks. The decision is made with patients and relatives.

While an increase in long-acting antibodies (LABB) is recommended in patients 12 years of age and older and weighing 40 kg or more, the recommended LAAB dosage is the same as in adults.

Journalists report that adding LAAB as a drug for the treatment of COVID-19 will help people have more access to expensive drugs. The drug is priced at 29,000 baht/via.

Incidentally, it canRead all the details here.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.